Lexicon Pharmaceuticals
LXRX
#6593
Rank
$0.86 B
Marketcap
$1.94
Share price
3.19%
Change (1 day)
39.57%
Change (1 year)

Lexicon Pharmaceuticals (LXRX) - Total debt

Total debt on the balance sheet as of June 2026 : $59.27 Million USD

According to Lexicon Pharmaceuticals 's latest financial reports the company's total debt is $59.27 Million USD. A companyโ€™s total debt is the sum of all current and non-current debts.

Lexicon Pharmaceuticals - Total debt on balance sheet (from 2000 to 2026)

Total debt by year

Year Total debt Change
2025-12-31$62.81 M-42.05%
2024-12-31$0.10 B2.2%
2023-12-31$0.10 B91.82%
2022-12-31$55.29 M2326.24%
2021-12-31$2.27 M-82.21%
2020-12-31$12.81 M-94.79%
2019-12-31$0.24 B0.3%
2018-12-31$0.24 B-0.27%
2017-12-31$0.24 B142.17%
2016-12-31$0.10 B-1.45%
2015-12-31$0.10 B-4.39%
2014-12-31$0.10 B392.15%
2013-12-31$21.87 M-6.71%
2012-12-31$23.45 M-5.8%
2011-12-31$24.89 M-12.6%
2010-12-31$28.48 M-57.47%
2009-12-31$66.96 M119.61%
2008-12-31$30.49 M-2.81%
2007-12-31$31.37 M-2.53%
2006-12-31$32.18 M-12.86%
2005-12-31$36.94 M-1.84%
2004-12-31$37.63 M-33.21%
2003-12-31$56.34 M1308.6%
2002-12-31$4 M
2000-12-31$2.84 M-40.44%
1999-12-31$4.77 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Thermo Fisher Scientific
TMO
$42.54 B 71,677.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
$2.54 B 4,191.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
$2.70 B 4,465.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
$36 M-39.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
$1.13 B 1,808.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
$0.25 B 326.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
$0.33 B 468.47%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$4.20 B 6,988.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
$0.34 M-99.41%๐Ÿ‡บ๐Ÿ‡ธ USA